Robichaud, N., Sonenberg, N., Ruggero, D. & Schneider, R. J. Translational control in cancer. Cold Spring Harb. Perspect. Biol. 11, a032896 (2019).
Kovalski, J. R., Kuzuoglu-Ozturk, D. & Ruggero, D. Protein synthesis control in cancer: selectivity and therapeutic targeting. EMBO J. 41, e109823 (2022).
Baker, R. T. & Board, P. G. The human ubiquitin-52 amino acid fusion protein gene shares several structural features with mammalian ribosomal protein genes. Nucleic Acids Res. 19, 1035–1040 (1991).
Morgan, E. et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study. eClinicalMedicine 47, 101404 (2022).
Hirata, Y., Noorani, A., Song, S., Wang, L. & Ajani, J. A. Early stage gastric adenocarcinoma: clinical and molecular landscapes. Nat. Rev. Clin. Oncol. 20, 453–469 (2023).
Manzanedo, I., Pereira, F., Perez-Viejo, E. & Serrano, A. Gastric cancer with peritoneal metastases: current status and prospects for treatment. Cancers 15, 1777 (2023).
Bhat, K. P., Umit Kaniskan, H., Jin, J. & Gozani, O. Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. Nat. Rev. Drug. Discov. 20, 265–286 (2021).
Meng, X. et al. Comprehensive analysis of histone modification-associated genes on differential gene expression and prognosis in gastric cancer. Exp. Ther. Med. 18, 2219–2230 (2019).
Zhang, Y. et al. Unique SMYD5 structure revealed by AlphaFold correlates with its functional divergence. Biomolecules 12, 783 (2022).
Zhang, Y. et al. SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters. Nat. Commun. 13, 3190 (2022).
Stender, J. D. et al. Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20. Mol. Cell 48, 28–38 (2012).
Husmann, D. & Gozani, O. Histone lysine methyltransferases in biology and disease. Nat. Struct. Mol. Biol. 26, 880–889 (2019).
Afjehi-Sadat, L. & Garcia, B. A. Comprehending dynamic protein methylation with mass spectrometry. Curr. Opin. Chem. Biol. 17, 12–19 (2013).
Stark, C. et al. BioGRID: a general repository for interaction datasets. Nucleic Acids Res. 34, D535–D539 (2006).
Williamson, N. A., Raliegh, J., Morrice, N. A. & Wettenhall, R. E. Post-translational processing of rat ribosomal proteins. Ubiquitous methylation of Lys22 within the zinc-finger motif of RL40 (carboxy-terminal extension protein 52) and tissue-specific methylation of Lys4 in RL29. Eur. J. Biochem. 246, 786–793 (1997).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583–589 (2021).
Eastham, M. J., Pelava, A., Wells, G. R., Watkins, N. J. & Schneider, C. RPS27a and RPL40, which are produced as ubiquitin fusion proteins, are not essential for p53 signalling. Biomolecules 13, 898 (2023).
Shi, Z. et al. Heterogeneous ribosomes preferentially translate distinct subpools of mRNAs genome-wide. Mol. Cell 67, 71–83.e7 (2017).
Guimaraes, J. C. & Zavolan, M. Patterns of ribosomal protein expression specify normal and malignant human cells. Genome Biol. 17, 236 (2016).
Ferretti, M. B. & Karbstein, K. Does functional specialization of ribosomes really exist? RNA 25, 521–538 (2019).
Miller, S. C., MacDonald, C. C., Kellogg, M. K., Karamysheva, Z. N. & Karamyshev, A. L. Specialized ribosomes in health and disease. Int. J. Mol. Sci. 24, 6334 (2023).
Panda, A. et al. Tissue- and development-stage-specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples. Nucleic Acids Res. 48, 7079–7098 (2020).
Lee, A. S., Burdeinick-Kerr, R. & Whelan, S. P. A ribosome-specialized translation initiation pathway is required for cap-dependent translation of vesicular stomatitis virus mRNAs. Proc. Natl Acad. Sci. USA 110, 324–329 (2013).
Gandin, V. et al. Polysome fractionation and analysis of mammalian translatomes on a genome-wide scale. J. Vis. Exp. 87, 51455 (2014).
Liu, S. et al. METTL13 methylation of eEF1A increases translational output to promote tumorigenesis. Cell 176, 491–504.e421 (2019).
Schmidt, E. K., Clavarino, G., Ceppi, M. & Pierre, P. SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods 6, 275–277 (2009).
Iwasaki, S. & Ingolia, N. T. The growing toolbox for protein synthesis studies. Trends Biochem. Sci. 42, 612–624 (2017).
Nielsen, P. J. & McConkey, E. H. Evidence for control of protein synthesis in HeLa cells via the elongation rate. J. Cell. Physiol. 104, 269–281 (1980).
Oertlin, C. et al. Generally applicable transcriptome-wide analysis of translation using anota2seq. Nucleic Acids Res. 47, e70 (2019).
Oertlin, C., Watt, K., Ristau, J. & Larsson, O. Anota2seq analysis for transcriptome-wide atudies of mRNA translation. Methods Mol. Biol. 2418, 243–268 (2022).
Truitt, M. L. & Ruggero, D. New frontiers in translational control of the cancer genome. Nat. Rev. Cancer 16, 288–304 (2016).
Lim, H. J., Zhuang, L. & Fitzgerald, R. C. Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications. J. Exp. Clin. Cancer Res. 42, 57 (2023).
Gregory, S. N. & Davis, J. L. CDH1 and hereditary diffuse gastric cancer: a narrative review. Chin. Clin. Oncol. 12, 25 (2023).
Pihlak, R., Fong, C. & Starling, N. Targeted therapies and developing precision medicine in gastric cancer. Cancers 15, 3248 (2023).
Seidlitz, T. et al. Mouse models of human gastric cancer subtypes with stomach-specific CreERT2-mediated pathway alterations. Gastroenterology 157, 1599–1614.e2 (2019).
Wong, H. H. & Chu, P. Immunohistochemical features of the gastrointestinal tract tumors. J. Gastrointest. Oncol. 3, 262–284 (2012).
Zhao, L. et al. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer. Cancer Sci. 104, 1640–1646 (2013).
Staudt, R. E., Carlson, R. D. & Snook, A. E. Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy. Cancer Biol. Ther. 23, 127–133 (2022).
Sadelain, M., Riviere, I. & Riddell, S. Therapeutic T cell engineering. Nature 545, 423–431 (2017).
Labanieh, L. & Mackall, C. L. CAR immune cells: design principles, resistance and the next generation. Nature 614, 635–648 (2023).
Qi, C. et al. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results. Nat. Med. 28, 1189–1198 (2022).
Carpenito, C. et al. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc. Natl Acad. Sci. USA 106, 3360–3365 (2009).
Lv, J. et al. Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer. J. Hematol. Oncol. 12, 18 (2019).
Jana, S. et al. Transcriptional–translational conflict is a barrier to cellular transformation and cancer progression. Cancer Cell 41, 853–870.e13 (2023).
Sfakianos, A. P., Raven, R. M. & Willis, A. E. The pleiotropic roles of eIF5A in cellular life and its therapeutic potential in cancer. Biochem. Soc. Trans. 50, 1885–1895 (2022).
Clarke, S. G. Protein methylation at the surface and buried deep: thinking outside the histone box. Trends Biochem. Sci. 38, 243–252 (2013).
Mealey-Farr, R. et al. Antibody toolkit to investigate eEF1A methylation dynamics in mRNA translation elongation. J. Biol. Chem. 299, 104747 (2023).
Simsek, D. & Barna, M. An emerging role for the ribosome as a nexus for post-translational modifications. Curr. Opin. Cell Biol. 45, 92–101 (2017).
Tian, X., Ju, H. & Yang, W. An ego network analysis approach identified important biomarkers with an association to progression and metastasis of gastric cancer. J. Cell. Biochem. 120, 15963–15970 (2019).
Reynoird, N. et al. Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer. Genes Dev. 30, 772–785 (2016).
Van Aller, G. S. et al. Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation. Epigenetics 7, 340–343 (2012).
Edmunds, J. W., Mahadevan, L. C. & Clayton, A. L. Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. EMBO J. 27, 406–420 (2008).
Schotta, G. et al. A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev. 22, 2048–2061 (2008).
Pagans, S. et al. The cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. Cell Host Microbe 7, 234–244 (2010).
Luger, K., Rechsteiner, T. J. & Richmond, T. J. in Chromatin Protocols. Methods in Molecular Biology, vol. 119 (ed. Becker P. B.) 1–16 (1999).
Zoabi, M. et al. Methyltransferase-like 21 C (METTL21C) methylates alanine tRNA synthetase at Lys-943 in muscle tissue. J. Biol. Chem. 295, 11822–11832 (2020).
Baymaz, H. I., Spruijt, C. G. & Vermeulen, M. in Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC). Methods Mol. Biol., vol. 1188 (ed. Warscheid, B.) 207–226 (2014).
Wingfield P. Protein precipitation using ammonium sulfate. Curr. Protoc. Protein. Sci. Appendix 3:Appendix-3F (2001).
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
Bushnell, B. BBMap: A Fast, Accurate, Splice-Aware Aligner (Lawrence Berkeley National Lab, 2014).
Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590–D596 (2013).
Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357–360 (2015).
Liao, Y., Smyth, G. K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 47, e47 (2019).
Pruitt, K. D. et al. RefSeq: an update on mammalian reference sequences. Nucleic Acids Res. 42, D756–D763 (2013).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2009).
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
Stacklies, W., Redestig, H., Scholz, M., Walther, D. & Selbig, J. pcaMethods—a Bioconductor package providing PCA methods for incomplete data. Bioinformatics 23, 1164–1167 (2007).
Wang, L., Wang, S. & Li, W. RSeQC: quality control of RNA-seq experiments. Bioinformatics 28, 2184–2185 (2012).
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
Mootha, V. K. et al. PGC-α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRxiv https://doi.org/10.1101/060012 (2021).
Guan, B.-J. et al. A unique ISR program determines cellular responses to chronic stress. Mol. Cell 68, 885–900.e6 (2017).
Mansour, F. H. & Pestov, D. G. Separation of long RNA by agarose–formaldehyde gel electrophoresis. Anal. Biochem. 441, 18–20 (2013).
Rahman, S. & Zenklusen, D. in Imaging Gene Expresson. Methods in Molecular Biology, vol. 1042 (ed. Shav-Tal, Y.) 33–46 (Humana Press, 2013).
Scott, D. D. et al. Nol12 is a multifunctional RNA binding protein at the nexus of RNA and DNA metabolism. Nucleic Acids Res. 45, 12509–12528 (2017).
Evans, R. et al. Protein complex prediction with AlphaFold-Multimer. Preprint at bioRxiv https://doi.org/10.1101/2021.10.04.463034 (2022).
The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202–209 (2014).
Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).
Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401–404 (2012).
Mazur, P. K. et al. SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Nature 510, 283–287 (2014).
Boussadia, O., Kutsch, S., Hierholzer, A., Delmas, V. & Kemler, R. E-cadherin is a survival factor for the lactating mouse mammary gland. Mech. Dev. 115, 53–62 (2002).
Jonkers, J. et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 29, 418–425 (2001).
Lesche, R. et al. Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32, 148–149 (2002).
Gao, X. et al. ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proc. Natl Acad. Sci. USA 105, 6656–6661 (2008).
Hingorani, S. R. et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437–450 (2003).
Skarnes, W. C. et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474, 337–342 (2011).
Raymond, C. S. & Soriano, P. High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2, e162 (2007).
More News
The Amazon’s gargantuan gardeners: manatees
Publisher Correction: Single-crystalline metal-oxide dielectrics for top-gate 2D transistors – Nature
The baseless stat that could be harming Indigenous conservation efforts